High-Energy Medical Cyclotron Project Approved in Nagpur

#GS-3 #Economy #Infrastructure #Science & Technology #Health #National #Gujarat

Context

The Maharashtra Cabinet led by Chief Minister Devendra Fadnavis officially approved a ₹300-crore High-Energy Medical Cyclotron Project (HEMCP) in Nagpur.

The High-Energy Medical Cyclotron Project (HEMCP) functions as an advanced nuclear medicine facility built around a particle accelerator.
This installation produces specialized and short-lived medical radioisotopes locally within the region.
These radioisotopes prove essential for advanced oncological imaging, targeted cancer treatments, and molecular research activities.

The cyclotron applies strong magnetic fields and alternating radio-frequency electric fields to speed up charged subatomic particles along a spiral path inside a vacuum chamber.
After reaching high kinetic energy levels, these particles form a focused beam and strike a stable target material like specific isotopes or liquid metals.
The high-energy collision changes the atomic nuclei of the target material and transforms stable atoms into short-lived radioactive isotopes such as Fluorine-18, Carbon-11, or Iodine-123.
Technicians transfer these raw radioisotopes to automated lead-shielded hot cells for chemical bonding with biological molecules like glucose.
This process creates medical-grade radiopharmaceuticals that patients can safely ingest or receive through intravenous methods for scanning purposes.

The facility sits in a central location and offers advanced cancer-care support across five states within a 500-km service radius.
It supplies critical radiopharmaceuticals to AIIMS Nagpur, NCI, and GMC to boost regional cancer-treatment capacity.
The ₹300-crore project utilizes a 50:50 financial architecture through joint funding from the Medical Education and Industry Departments alongside 30 hectares of allotted land.
A dedicated Special Purpose Vehicle under Mahacare oversees operations to guarantee professional management and coordination.

The facility produces isotopes like Fluorine-18 for PET-CT scans to help doctors detect cancer cells early and accurately.
It supports targeted nuclear medicine therapies that deliver focused radiation straight to tumors while protecting healthy surrounding tissue.
The center acts as a research hub for clinical trials and assists in the development of new imaging tracers and cancer treatments.
Local production guarantees fast delivery of short-lived isotopes to hospitals for accurate patient-specific diagnostic dosing.